Menu

ASH 2015: Wow – What a Meeting!

| Linda Huguelet

Trying to process all of the information that I heard at The American Society of Hematology (ASH) Conference is a bit overwhelming. But, the one thing I can say (without looking at my many pages of notes) is that advances in multiple myeloma treatments are on the fast-track and a countless number of researchers are […]

New Approvals – Now What?

| Linda Huguelet

The American Society of Hematology (ASH) Conference and Exhibition is filled with much excitement and buzz about the approval of two monoclonal antibodies Darzalex (daratumumab)and Empliciti (elotuzumab). Monoclonal antibodies are a class of drugs that we’ve all been eagerly awaiting – the Exhibit Hall is splashed with large images of “Now Approved,” and “It’s here.” […]

Let The Debates Begin . . .

| Linda Huguelet

The room was overflowing with more than 1,000 medical professionals from around the world who have come to the American Society of Hematology (ASH) Meeting and Exposition to learn the latest developments and how they can use them to benefit their patients back home. The first day in Orlando kicked off with a pre-conference Symposium […]

Imagine Moving Forward

| Linda Huguelet

I start every day before work with a 2.5 mile walk.  And, every day I look down at the IMF bracelet around my wrist that reads “Imagine Moving Forward.”   I’m so grateful for the advances in myeloma treatments that enable me to continue working and to lead a pretty active, normal lifestyle. Since my diagnosis […]